3^rd International Conference on Genetics and Molecular Biology April 18-19, 2022 Miami, USA

Amal Brahimi, 26 years old women. She is an agronomist engineer since 2016. In addition she is second year PhD student at the Moulay ismail University, Meknes Morocco. She is a member of the 1Laboratory of vegetal Biotechnology and molecular biology. In January 2019, she has done training at the Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, for the genetic analysis

Department of Plants and Crops, Faculty of Bioscience Engineering

Simon Raymond is a Consultant (medicine and surgery) specialising in Medical and Scientific Research and an Alumnus of Melbourne University (Rank of Number 1 in Australia and Number 33 in the World). The above stated Researcher has acted as a Reviewer for the respected Medical Journal of Australia, has received invitations internationally to review from prestigious medical journals including Journal of American Medical Association Network

He has received award in recognition of his research by Royal Australasian College of Surgeons (PSC, 2006) and invited to conferences internationally as an official Delegate and Researcher, including that in USA and China. Dr Simon Raymond is a graduate of medical school who shifted from clinical practitioner

Elsayed Ahmed Elnashar, Full-Professor of textiles Apparel, Kaferelsheikh University, Egypt. Born in 19 /8/1965. Have Ph.D. 2000, Msc.1995, Bsc.1989, Helwan University. Diploma1985advanced industrial textiles institute. He holds several academic administrative positions: Dean, Vice Dean, Head of Department, He has many textiles patents, Member of international scientific committees. Development of Faculties of Education commissioned of Supreme Council of Egyptian Universities. Have design books been published in Germany and Ukraine? Has published over 205 scientific Articles. Editorial board member & Reviewer for more than 115 journals, an organizer for more than 95 conferences and workshop over the world, Founder and editor of two scientific journals. And Smartex Conference Egypt. Member of the editorial board of several international journals and conferences, He has made many scientific agreements with European & African universities

Membrane filters if textiles, Membrane filters if textiles for water desalination, LASER-JET TECHNOLOGY ON WEAVING MACHINE, Antimicrobial Throw Volume Porosity, Membrane Technology for Filtrations: Water/Wastewater, Air Conditions, Cement Factory, Gas And Petroleum - Solar textiles (SOLATEX) of composite fabrics, structures as alternative energy, Functional Nano biodegradable, Computational Mathematics, Fluid Mechanics

Dr. Hongjun Wang has completed her Ph.D. from China Agricultural University and postdoctoral studies at the University of Rome, “La Sapienza” and St. Jude Children’s Hospital. She was an instructor and Assistant Professor at the Harvard Medical School/Beth Israel Deaconess Medical Center from 2001-2011. She is now a full Professor and the Scientific Director of the Center for Cellular Therapy, at the Medical University of South Carolina, USA. Dr. Wang has published more than 50 papers in reputed journals and has been serving as an editorial board member of repute.

His research interest includes Cell Therapy, Stem cell, surgery, Gene therapy

Sergey Suchkov received his MD from Astrakhan State Medical University. In 1985, he received his Ph.D. from the I M Sechenov Moscow Medical Academy and in 2001, his Doctorship Degree at the Nat Institute of Immunology, Russia. From 1987 through 1989, he was a Senior Researcher at, Koltzov Institute of Developmental Biology. From 1989 through 1995, he was the Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, he was the Chair of the Department of Clinical Immunology, Moscow Clinical Research Institute. He was an Exe Secretary-in-Chief of the Editorial Board of Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, he is a Chair at the Department for Personalized and Translational Medicine, I M Sechenov First Moscow State Medical University. He is a Member of the New York Academy of Sciences, USA; American Chemical Society (ACS), USA; American Heart Association (AHA), USA; EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ARVO (American Association for Research in Vision and Ophthalmology); ISER (International Society for Eye Research) and PMC (Personalized Medicine Coalition), Washington, USA.

Translational Medicine

Farzin Farzaneh holds the Chair of Molecular Medicine at King’s College London. He has published over 250 research articles with an average citation of over 30, and an Impact Factor of 47. He has run a licensed GMP facility at King’s College London, since 2001, for the production of cell and gene therapy-based investigational medicinal products. Farzin has extensive industrial and academic collaborations, including research council, charitable and pharmaceutical sponsorships of £25M. He has initiated a number of clinical trials in novel applications of gene therapy and holds MHRA licenses (IMPs and “Specials"). He is a Qualified Person (QP) for release of cell and gene therapy products in the UK and EU and an Individual Designate under a Human Tissue Authority license that allows procurement, testing, processing, distribution, and/or import/export of tissues and or cells intended for human applications. He is also appointed by the Commission on Human Medicines, as a member of the Clinical Trials, Biologicals & Vaccines Expert Advisory Group since 2016.

Farzaneh research interest includes Cell and Gene Therapy, Tissue Science, Human Medicines, Clinical Trials, Biologicals & Vaccines

Born in Rome the 7/12/1949, 5 children, held the medical degree at the University of Rome “La Sapienza” with full honour. VC is specialist in Clinical of Infectious Diseases (University of Rome) and in Hygiene and Public Health (University of Pisa), and PhD in Immunology (Brunnel University, England). His doctorate and post-doc experience has been carried out at the Clinical Research Centre in Harrow (England). He has been an Assistant in Microbiology, and Associate professor in Immunology at the University of Pisa. From 2000 to now, VC is a Full Professor of Immunology and Director of the UNESCO Chair in Biotechnology at the University of Rome Tor Vergata. VC has been also President (2007-2010) of the Board of the National Institute for Infectious Diseases “Lazzaro Spallanzani” in Rome, Italy. He is a consultant for several agencies of the United Nations (UNESCO, UNDP, OMS) and is the scientific coordinator of several European and International Projects. VC has been Scientific Director and member of the Board of the International Reference Centre for AIDS “Chantal Biya” in Yaoundé, Cameroon and President of the University Spinoff Eurobiopark (European Group of Biotechnology at the Tior Vergata Science Park). VC published over 260 scientific publications on peer-review journals (Nature, Journal of Immunology, Infection and Immunity, Journal of Infectious Diseases, Immunology, Clinical Experimental Immunology, A, IDS, AIDS and Human Retrovirus Journal, etc.) in the sector of Microbial Immunology and Infectious Diseases, with special focus on AIDS and Tuberculosis.

Immunology, Virology, Biotechnology

Frank Staal is a full professor of Molecular Stem Cell biology at Leiden University School of Medicine (LUMC). He is co-director of the LUMC Flow Cytometry Core Facility (FCF) and holds teaching positions at the Delft University of Technology and Erasmus MC, Rotterdam, The Netherlands. He was a postdoctoral fellow of the Royal Academy of Arts and Sciences, a member of the Health Council that advises the Dutch Government (on neonatal screening), and coordinates two large EU H2020 consortia on gene therapy for immune disorders. The research of Frank J.T. Staal focuses on the molecular regulation of immature T lymphocyte development and hematopoietic stem cell biology.

Retroviral transduction; Gene therapy; Stem cell assays; FTOC; Reporter gene assays; Immunology assays; T cell clones; Molecular biological techniques; Protein chemistry; Kinase assays